154 related articles for article (PubMed ID: 27107657)
1. Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia.
Goasguen JE; Bennett JM; Bain BJ; Brunning RD; Vallespí MT; Tomonaga M; Zini G; Renault A;
Leuk Res; 2016 Jun; 45():75-81. PubMed ID: 27107657
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
[TBL] [Abstract][Full Text] [Related]
3. [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].
Tomonaga M; Jinnai I; Kuriyama K; Nonaka H; Amenomori T; Matsuo T; Yoshida Y; Sasagawa I; Sadamori N; Ichimaru M
Rinsho Ketsueki; 1989 Oct; 30(10):1788-99. PubMed ID: 2593245
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of utility of immunohistochemistry markers as a tool for objective diagnosis of low-grade myelodysplastic syndrome in routine reporting: Prospective observational study.
Juneja R; Pati H; Dange P; Gupta G; Mahapatra M; Tyagi S; Saxena R
Indian J Pathol Microbiol; 2022; 65(4):879-885. PubMed ID: 36308198
[TBL] [Abstract][Full Text] [Related]
5. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
Thiele J; Quitmann H; Wagner S; Fischer R
J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
[TBL] [Abstract][Full Text] [Related]
6. Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.
Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
Br J Haematol; 2018 Aug; 182(4):526-533. PubMed ID: 29917221
[TBL] [Abstract][Full Text] [Related]
7. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
Ohshima K; Kikuchi M; Takeshita M
J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
[TBL] [Abstract][Full Text] [Related]
8. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?
Wong KF; Chan JK
Br J Haematol; 1991 Apr; 77(4):509-14. PubMed ID: 2025576
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of immunocytochemical staining versus Giemsa stain for detecting dysmegakaryopoiesis in myelodysplastic syndromes (MDS).
Kawaguchi M; Nehashi Y; Aizawa S; Toyama K
Eur J Haematol; 1990 Feb; 44(2):89-94. PubMed ID: 2318299
[TBL] [Abstract][Full Text] [Related]
10. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes.
Thiele J; Titius BR; Kopsidis C; Fischer R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):275-82. PubMed ID: 1279889
[TBL] [Abstract][Full Text] [Related]
11. [An immunohistochemical study on megakaryocytes in patients with myelodysplastic syndromes].
Liu SQ; Liu XF; Song SJ
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):288-90. PubMed ID: 7874762
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
13. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia features of myelodysplastic syndrome in ethnically Chinese people.
Xiong B; Tang ZH; Zou P; Yue QF; Chen WX; Liu XY
Acta Haematol; 2014; 131(2):126-32. PubMed ID: 24158033
[TBL] [Abstract][Full Text] [Related]
15. Deep learning application of the discrimination of bone marrow aspiration cells in patients with myelodysplastic syndromes.
Lee N; Jeong S; Park MJ; Song W
Sci Rep; 2022 Nov; 12(1):18677. PubMed ID: 36333407
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
[TBL] [Abstract][Full Text] [Related]
17. Difference in megakaryocyte expression of GATA-1, IL-6, and IL-8 associated with maintenance of platelet counts in patients with plasma cell neoplasm with dysmegakaryopoiesis.
Kim H; Lee MK; Kim HR
Exp Hematol; 2019 May; 73():13-17.e2. PubMed ID: 30825517
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
Das R; Hayer J; Dey P; Garewal G
Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
[TBL] [Abstract][Full Text] [Related]
19. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
[TBL] [Abstract][Full Text] [Related]
20. A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes.
Feng G; Gale RP; Cui W; Cai W; Huang G; Xu Z; Qin T; Zhang Y; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Wang J; Cui Y; Xiao Z
Exp Hematol Oncol; 2015; 5():12. PubMed ID: 27127725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]